Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model

References

• Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003;133:3244S–3246S.
   Web of Science ®Google Scholar
• Cascella M, Bimonte S, Muzio MR, et al. The efficacy of epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice, infect. Agent Cancer. 2017;12:1–7.
   PubMed Web of Science ®Google Scholar
• Mandel SA, Amit T, Kalfon L, et al. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr. 2008;138:1578S–1583S.
   PubMed Web of Science ®Google Scholar
• Leichsenring A, Bäcker I, Furtmüller PG, et al. Long-term effects of (-)-epigallocatechin gallate (EGCG) on pristane-induced arthritis (PIA) in female dark agouti rats. PLoS One. 2016;11:e0152518– e0152527.
   PubMed Web of Science ®Google Scholar
• Tominari T, Matsumoto C, Watanabe K, et al. Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice. FEBS Open Bio. 2015;5:522–527.
   PubMed Web of Science ®Google Scholar
• Rahmani A, Al Shabrmi FM, Allemailem KS, et al. Implications of green tea and its constituents in the prevention of cancer via the modulation of cell signalling pathway. Biomed Res Int. 2015;2015:1–8.
   Google Scholar
• Lu YP, Lou YR, Xie JG, et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA. 2002;99:12455–12460.
   Google Scholar
• Thangapazham RL, Singh AK, Sharma A, et al. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007;245:232–241.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys. 2010;501:65–72.
   PubMed Web of Science ®Google Scholar
• Zhu QY, Zhang A, Tsang D, et al. Stability of green tea catechins. J Agric Food Chem. 1997;45:4624–4628.
   Web of Science ®Google Scholar
• Sang S, Lambert JD, Ho CT, et al. The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011;64:87–99.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Yang CS. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res Fundam Mol Mech Mutagen. 2003;523–524:201–208.
   PubMed Web of Science ®Google Scholar
• Lu H, Meng X, Yang CS. Enzymology of methylation of tea catechins and inhibition of catechol- O -methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos. 2003;31:572–579.
   PubMed Web of Science ®Google Scholar
• Hong J, Lambert JD, Lee SH, et al. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun. 2003;310:222–227.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (–)-epigallocatechin-3-gallate and (–)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem. 1997;61:1981–1985.
   PubMed Web of Science ®Google Scholar
• Rainer SG, Muller H, Mader K. Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
   PubMed Web of Science ®Google Scholar
• Quintanilla-Carvajal MX, Camacho-Díaz BH, Meraz-Torres LS, et al. Nanoencapsulation: a new trend in food engineering processing. Food Eng Rev. 2010;2:39–50.
   Web of Science ®Google Scholar
• Xue J, Tan C, Zhang X, et al. Fabrication of epigallocatechin-3-gallate nanocarrier based on glycosylated casein: stability and interaction mechanism. J Agric Food Chem. 2014;62:4677–4684.
   PubMed Web of Science ®Google Scholar
• Kumar G, Sharma S, Shafiq N, et al. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis. Drug Deliv. 2011;18:65–73.
   PubMed Web of Science ®Google Scholar
• Dudhipala N, Veerabrahma K. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Drug Dev Ind Pharm. 2015;41:1968–1977.
   PubMed Web of Science ®Google Scholar
• Mehnert W. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 2009;37:508–513.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release. 2008;129:1–10.
   PubMed Web of Science ®Google Scholar
• Zheng W, Jain A, Papoutsakis D, et al. Selection of oral bioavailability enhancing formulations during drug discovery. Drug Dev Ind Pharm. 2012;38:235–247.
   PubMed Web of Science ®Google Scholar
• Qi C, Chen Y, Jing QZ, et al. Preparation and characterization of catalase-loaded solid lipid nanoparticles protecting enzyme against proteolysis. Int J Mol Sci. 2011;12:4282–4293.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release. 1994;30:83–96.
   Web of Science ®Google Scholar
• Radhakrishnan R, Kulhari H, Pooja D, et al. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem Phys Lipids. 2016;198:51–60.
   PubMed Web of Science ®Google Scholar
• Ma Q, Xia Q, Lu Y, et al. Preparation of tea polyphenols-loaded solid lipid nanoparticles based on the phase behaviors of hot microemulsions. Solid State Phenom. 2007;123:705–708.
   Google Scholar
• Dube A, Nicolazzo JA, Larson I. Assessment of plasma concentrations of (À) -epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverage. Food Chem. 2011;128:7–13.
   PubMed Web of Science ®Google Scholar
• Ravi TP, Mandal AKA. Effect of alcohol on release of green tea polyphenols from casein nanoparticles and its mathematical modeling. Res J Biotechnol. 2015;10:99–104.
   Web of Science ®Google Scholar
• Chen L, Lee M, Li HE, et al. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab Dispos. 1997;25:1045–1050.
   PubMed Web of Science ®Google Scholar
• Chinedu E, Arome D, Ameh FS. A new method for determining acute toxicity in animal models. Toxicol Int. 2013;20:224–227.
   PubMedGoogle Scholar
• Galindo-Rodriguez S, Allémann E, Fessi H, et al. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 2004;21:1428–1439.
   PubMed Web of Science ®Google Scholar
• Mohanraj VJ, Chen Y, Chen M. Nanoparticles – a review. Trop J Pharm Res. 2006;5:561–573.
   Google Scholar
• Saneja A, Nayak D, Srinivas M, et al. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Eur J Pharm Sci. 2017;97:79–91.
   PubMed Web of Science ®Google Scholar
• Ponnuraj R, Janakiraman K, Gopalakrishnan S, et al. Formulation and development of capsules containing rosuvastatin calcium nanoparticles and epigallocatechin gallate nanoparticles. Indo Am J Pharm Res. 2015;5:2217–2231.
   Google Scholar
• Akbari Z, Amanlou M, Karimi-sabet J, et al. Preparation and characterization of solid lipid nanoparticles through rapid expansion of supercritical solution. Int J Pharml Sci Res. 2014;5:1693–1704.
   Google Scholar
• Hamishehkar H, Shokri J, Fallahi S, et al. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite. Drug Dev Ind Pharm. 2015;41:1640–1646.
   PubMed Web of Science ®Google Scholar
• Panyam J, William D, Dash A, et al. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci. 2004;93:1804–1814.
   PubMed Web of Science ®Google Scholar
• Gómez-Gaete C, Tsapis N, Besnard M, et al. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm. 2007;331:153–159.
   PubMed Web of Science ®Google Scholar
• Singh NA, Mandal AKA, Khan ZA. Fabrication of PLA-PEG nanoparticles as delivery systems for improved stability and controlled release of catechin. J Nanomater. 2017;2017:1.
   Google Scholar
• Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67:217–223.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Yang CS. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm. 2007;4:819–825.
   PubMed Web of Science ®Google Scholar
• Huang S, Zhang Q, Li H, et al. Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method. Eur J Pharm Biopharm. 2018;130:108–114.
   PubMed Web of Science ®Google Scholar
• Saraogi GK, Gupta P, Gupta UD, et al. Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Int J Pharm. 2010;385:143–149.
   PubMed Web of Science ®Google Scholar
• Kulandaivelu K, Mandal AKA. Improved bioavailability and pharmacokinetics of tea polyphenols by encapsulation into gelatin nanoparticles. IET Nanobiotechnol. 2017;11:469–476.
   PubMed Web of Science ®Google Scholar